{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T11:16:19Z","timestamp":1788434179293,"version":"build-2803163510"},"reference-count":21,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:00:00Z","timestamp":1787961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009687","name":"Wroclaw Medical University","doi-asserted-by":"publisher","award":["UMW SUB.C170.21.027"],"award-info":[{"award-number":["UMW SUB.C170.21.027"]}],"id":[{"id":"10.13039\/501100009687","id-type":"DOI","asserted-by":"publisher"}]},{"award":["UMW SUB.C170.21.027"],"award-info":[{"award-number":["UMW SUB.C170.21.027"]}],"id":[{"id":"https:\/\/ror.org\/01qpw1b93","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Metabolites"],"abstract":"<jats:p>Background: Metabolic complications and weight gain have emerged as primary concerns among virologically suppressed and immunologically competent people living with HIV. Particularly integrase strand transfer inhibitors (INSTIs) and tenofovir alafenamide (TAF) are being connected with this issue. Objectives: This study aimed to evaluate the prevalence of metabolic syndrome (MetS) and its components within a highly homogeneous, virologically suppressed cohort, assessing the impact of antiretroviral therapy (ART) and HIV-unrelated factors. Methods: We conducted a single-center cross-sectional analysis of 93 HIV-positive patients receiving stable ART for &gt;2 years, in Wroc\u0142aw, Poland. To minimize confounding, individuals with HBV\/HCV co-infections or significant alcohol use were excluded. Participants were stratified primarily by regimen, INSTI\/TAF-based (n = 50) vs. PI\/TAF-based (n = 28), and secondarily by the particular drugs taken. Clinical assessment included anthropometric parameters, lipid profiles, and glucose metabolism. Results: The prevalence of MetS was 10.8%. No statistically significant differences were observed in the incidence of MetS, insulin resistance, or dyslipidemia between the INSTI\/TAF and PI\/TAF groups. A marginally significant trend toward lower total cholesterol was identified in patients receiving dolutegravir\/TAF compared to those on darunavir\/TAF. Conclusions: In this stable Caucasian cohort with long-term viral suppression, we found no statistically significant differences in metabolic outcomes between modern INSTI- and PI-based regimens. However, due to the limited sample size and low statistical power, these findings do not prove clinical equivalence. Our results suggest that in particular tightly selected settings of well-controlled patients, traditional risk factors and lifestyle may remain the primary drivers of metabolic health, although modest drug-related effects cannot be ruled out.<\/jats:p>","DOI":"10.3390\/metabo16090631","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T09:21:19Z","timestamp":1788168079000},"page":"631","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Determinants of Metabolic Syndrome in Virally Suppressed People Living with HIV: A Single-Center Comparative Analysis of Antiretroviral Regimens"],"prefix":"10.3390","volume":"16","author":[{"given":"Micha\u0142","family":"Bia\u0142y","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Liver Diseases and Acquired Immune Deficiencies, Wroclaw Medical University, 51-149 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"}]},{"given":"Ma\u0142gorzata","family":"Inglot","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Liver Diseases and Acquired Immune Deficiencies, Wroclaw Medical University, 51-149 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e295","DOI":"10.1016\/S2352-3018(23)00028-0","article-title":"Life Expectancy after 2015 of Adults with HIV on Long-Term Antiretroviral Therapy in Europe and North America: A Collaborative Analysis of Cohort Studies","volume":"10","author":"Trickey","year":"2023","journal-title":"Lancet HIV"},{"key":"ref_2","first-page":"596","article-title":"CROI 2025: Metabolic and Other Complications of HIV Infection","volume":"33","author":"Sarkar","year":"2025","journal-title":"Top. Antivir. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/COH.0000000000000755","article-title":"HIV and Cardiovascular Disease: The Role of Inflammation","volume":"17","author":"Funderburg","year":"2022","journal-title":"Curr. Opin. HIV AIDS"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ando.2024.05.005","article-title":"HIV and Adipose Tissue: A Long History Linked to Therapeutic Classes of Antiretrovirals","volume":"85","author":"Capeau","year":"2024","journal-title":"Ann. D\u2019Endocrinol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e321","DOI":"10.1016\/S2352-3018(23)00328-4","article-title":"Associations between Change in BMI and the Risk of Hypertension and Dyslipidaemia in People Receiving Integrase Strand-Transfer Inhibitors, Tenofovir Alafenamide, or Both Compared with Other Contemporary Antiretroviral Regimens: A Multicentre, Prospective Observational Study from the RESPOND Consortium Cohorts","volume":"11","author":"Byonanebye","year":"2024","journal-title":"Lancet HIV"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e306","DOI":"10.1016\/S2352-3018(25)00354-6","article-title":"Risk of Obesity, Diabetes, Hypertension, and Major Adverse Cardiovascular Events after a Switch to an Integrase Inhibitor: A Target Trial Emulation in REPRIEVE","volume":"13","author":"Kileel","year":"2026","journal-title":"Lancet HIV"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/COH.0000000000000834","article-title":"The Pathogenesis of Obesity in People Living with HIV","volume":"19","author":"Bailin","year":"2024","journal-title":"Curr. Opin. HIV AIDS"},{"key":"ref_8","unstructured":"UNAIDS (2026, May 01). 2024 Global AIDS Report\u2014The Urgency of Now: AIDS at a Crossroads. Available online: https:\/\/www.unaids.org\/en\/resources\/documents\/2024\/global-aids-update-2024."},{"key":"ref_9","unstructured":"Fuda\u0142a, J. (2026, May 01). Bezpieczne Picie Alkoholu. Available online: http:\/\/www.mp.pl\/social\/article\/69551."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis Model Assessment: Insulin Resistance and Beta-Cell Function from Fasting Plasma Glucose and Insulin Concentrations in Man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.5114\/aoms\/152921","article-title":"Metabolic Syndrome\u2014A New Definition and Management Guidelines. A joint position paper by the Polish Society of Hypertension, Polish Society for the Treatment of Obesity, Polish Lipid Association, Polish Association for Study of Liver, Polish Society of Family Medicine, Polish Society of Lifestyle Medicine, Division of Prevention and Epidemiology Polish Cardiac Society, \u201cClub 30\u201d Polish Cardiac Society, and Division of Metabolic and Bariatric Surgery Society of Polish Surgeons","volume":"18","author":"Dobrowolski","year":"2022","journal-title":"Arch. Med. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/jama.2018.21167","article-title":"HIV Viral Load and Transmissibility of HIV Infection: Undetectable Equals Untransmittable","volume":"321","author":"Eisinger","year":"2019","journal-title":"JAMA"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"ofad494","DOI":"10.1093\/ofid\/ofad494","article-title":"The Perils of Overly Sensitive Viral Load Testing for Persons with Human Immunodeficiency Virus","volume":"10","author":"Rodriguez","year":"2023","journal-title":"Open Forum Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Trachunthong, D., Tipayamongkholgul, M., Chumseng, S., Darasawang, W., and Bundhamcharoen, K. (2024). Burden of Metabolic Syndrome in the Global Adult HIV-Infected Population: A Systematic Review and Meta-Analysis. BMC Public Health, 24.","DOI":"10.1186\/s12889-024-20118-3"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12981-025-00732-w","article-title":"Long-Term Metabolic Changes with Bictegravir\/Emtricitabine\/Tenofovir Alafenamide or Dolutegravir-Containing Regimens for HIV","volume":"22","author":"Daar","year":"2025","journal-title":"AIDS Res. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"ofae752","DOI":"10.1093\/ofid\/ofae752","article-title":"Preswitch Regimens Associated with Weight Gain Among Persons with HIV Who Switch to Integrase Inhibitor\u2013Containing Regimens","volume":"12","author":"Cutshaw","year":"2025","journal-title":"Open Forum Infect. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/COH.0000000000000833","article-title":"Recent Data on the Role of Antiretroviral Therapy in Weight Gain and Obesity in Persons Living with HIV","volume":"19","author":"Capeau","year":"2024","journal-title":"Curr. Opin. HIV AIDS"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e003136","DOI":"10.1136\/bmjdrc-2022-003136","article-title":"Association between Integrase Strand Transfer Inhibitor Use with Insulin Resistance and Incident Diabetes Mellitus in Persons Living with HIV: A Systematic Review and Meta-Analysis","volume":"11","author":"Mulindwa","year":"2023","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jacc.2023.04.050","article-title":"Dyslipidemia in Human Immunodeficiency Virus Disease","volume":"82","author":"Kalra","year":"2023","journal-title":"JACC"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e13908","DOI":"10.1111\/obr.13908","article-title":"Weight Gain, Obesity, and the Impact of Lifestyle Factors among People Living with HIV: A Systematic Review","volume":"26","author":"Gilberti","year":"2025","journal-title":"Obes. Rev."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Tiozzo, E., Rodriguez, A., Konefal, J., Farkas, G.J., Maher, J.L., and Lewis, J.E. (2021). The Relationship between HIV Duration, Insulin Resistance and Diabetes Risk. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18083926"}],"container-title":["Metabolites"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-1989\/16\/9\/631\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T10:32:54Z","timestamp":1788431574000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-1989\/16\/9\/631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,29]]},"references-count":21,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["metabo16090631"],"URL":"https:\/\/doi.org\/10.3390\/metabo16090631","relation":{},"ISSN":["2218-1989"],"issn-type":[{"value":"2218-1989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,29]]}}}